ARCHIVES

Clinical Trial System Inefficient, UPCI Director Tells Senate

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended

February 24, 2012

NCI To Fund 3,232, Research Project Grants In Fiscal 1993

January 15, 1993

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval

June 11, 1982